We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax Attempts to Gain FDA Acceptance of Opana ER ANDA
Impax Attempts to Gain FDA Acceptance of Opana ER ANDA
December 11, 2007
Impax Laboratories has responded to the FDA after the agency withdrew acceptance of the company’s abbreviated new drug application (ANDA) for generic Opana ER.